Analysts expect OSR Health, Inc. to report revenue of 800,092.80 for Q2 26, against a range of 741,634.82 to 858,550.78. The most recent reported quarter, Q1 26, came in at 484,057.41, a 40.5% miss against the 814,187.40 consensus.
| Metric | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.14 M | 627,747.00 | 381,269.00 | 484,057.41 | - | - | - |
| High Estimate | - | 774,360.92 | 779,602.36 | 845,326.81 | 858,550.78 | 875,162.66 | 824,215.75 |
| Low Estimate | - | 708,224.28 | 644,462.84 | 783,047.99 | 741,634.82 | 743,524.54 | 771,118.25 |
| Consensus Estimate | - | 741,292.60 | 712,032.60 | 814,187.40 | 800,092.80 | 809,343.60 | 797,667.00 |
Analysts expect OSR Health, Inc. to report earnings per share of -0.29 for Q2 26, against a range of -0.31 to -0.27. The most recent reported quarter, Q1 26, came in at -0.09, a 68.7% beat against the -0.30 consensus.
| Metric | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.26 | -0.12 | -0.25 | -0.09 | - | - | - |
| High Estimate | - | -0.10 | -0.09 | -0.29 | -0.27 | -0.26 | -0.26 |
| Low Estimate | - | -0.12 | -0.11 | -0.31 | -0.31 | -0.30 | -0.28 |
| Consensus Estimate | - | -0.11 | -0.10 | -0.30 | -0.29 | -0.28 | -0.27 |